期刊文献+

性别对辛伐他汀治疗2型糖尿病伴血脂异常的疗效影响 被引量:1

下载PDF
导出
摘要 目的:观察不同性别血脂异常的2型糖尿病患者服用辛伐他汀的降脂疗效,以指导辛伐他汀的个体化用药。方法:对我院80例伴血脂异常的2型糖尿病患者使用辛伐他汀进行降脂治疗,根据性别分为男、女两组。分别对患者服药后4、8、32周的胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)进行测定。结果:服用辛伐他汀4周后男性组的TC、TG、LDL值水平较女性组更低;8周后男性组TC、LDL值较女性组更低;32周后男性组TC、TG值较女性组更低,但HDL值男性组较女性组更高。结论:性别对血脂异常的2型糖尿病患者服用辛伐他汀的降脂疗效有影响,辛伐他汀对伴血脂异常的男性2型糖尿病患者的降脂疗效较女性更好。
出处 《实用中西医结合临床》 2013年第6期13-14,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
基金 江西省卫生厅科技计划项目(编号:20081096)
  • 相关文献

参考文献5

二级参考文献39

  • 1胡永芳,周宏灏.CYP3A4,CYP3A5和MDR1基因多态性对环孢素处置的影响[J].中国药理学通报,2005,21(3):257-261. 被引量:34
  • 2许樟荣,王玉珍,王先从,伍春荣,余红亚,胡莲娜,杨晋德,黄列军,杨文生,刘先华,韦丽青,敬华,李淑媛.糖尿病慢性并发症与糖尿病治疗关系的调查[J].中华医学杂志,1997,77(2):119-122. 被引量:82
  • 3van SCHAIK RH, van der HEIDEN IP, van den ANKER JN, et al. CYP3A5 variant allele frequencies in Dutch Caucasians [J]. Clin Chem, 2002, 48(10) : 1668-1671.
  • 4HOFFMEYER S, BURK O, von RICHTER O, et al. Functional polymorphism of the human multidrug-resistance gene : multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J]. Proc Natl Acad Sci USA, 2000, 97(7) : 3473-3478.
  • 5TIRONA RG, LEAKE BF, MERINO G, et al. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European-and African- Americans[J]. J Biol Chem, 2001, 276(38): 35669-35675.
  • 6LEE E, RYAN S, BIRMINGHAM B, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment [J]. Clin Pharmacol Ther, 2005, 78(4): 330-341.
  • 7COUTURE P, OTVOS JD, CUPPLES LA, et al. Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study[J]. J Lipid Res, 1999, 40(10) : 1883-1889.
  • 8MIWA K, INAZU A, KOBAYASHI J, et al. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects[J]. Clin Sci(Lond), 2005, 109(2): 183-188.
  • 9KUEHL P, ZHANG J, LIN Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression[J]. Nat Genet, 2001, 27(4): 383-391.
  • 10HOFMAN MK, PRINCEN HM, ZWINDERMAN AH. Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol7α-hydroxylase)influences the progression of atherosclerosis and risk of new clinical events [J]. Clin Sci (Lond), 2005, 108(6) : 539-545.

共引文献31

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部